📰 Single Ascending Dose Study News
Page 2 - Single Ascending Dose Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Single Ascending Dose Study. Real-time updates on events, politics, business and more.
January 19, 2022
AlzeCure gets late-breaking abstract on NeuroRestore ACD856 clinical data accepted to AD/PD 2022 conferenceAlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Al...
January 18, 2022
STOCKHOLM, SWEDEN / ACCESSWIRE / January 18, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
November 3, 2021
Late breaker will show ADUHELM effect on plasma pTau181 reduction, and its correlation with amyloid beta and slowing cognitive and functional decline.Additional phase 3b late breaker data will shed light